OpenVSafe by OpenVAERS
Search V-safe

KAE-14703-71567

2 vaccinations 9 coded responses 15 check-ins 9 free-text entries 6 call cases
Sex
Female
Age at first dose
31-35
ZIP prefix
462 / IN
Registered
2021-01-30
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2020-12-28
    Dose 1 — Moderna
  2. 2021-01-30
    Registered in v-safe
  3. 2021-01-30
    Dose 2 — Moderna
  4. 2021-01-30
    Health check-in — day 0, dose 2
    Feeling: Fair · Site: Pain · Headache, Muscle or body aches · Be unable to do your normal daily activities
    Adult check-in
  5. 2021-01-31
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Pain, Swelling · Headache
    Adult check-in
  6. 2021-02-01
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Pain · None
    Adult check-in
  7. 2021-02-02
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  8. 2021-02-04
    Survey response — days 1–6 daily, dose 2
    MedDRA: Lymphadenopathy — Feeling: Good
    Free text: Lymphadenopathy
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  9. 2021-02-05
    Survey response — days 1–6 daily, dose 2
    MedDRA: Lymphadenopathy — Feeling: Good
    Free text: Lymphadenopathy
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  10. 2021-02-06
    Survey response — day 7, dose 2
    MedDRA: Lymphadenopathy, Night sweats — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: Lymphadenopathy, night sweats
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  11. 2021-02-06
    Report sent to call center — day 7, dose 2
    Get care from a doctor or other healthcare professional
    1 call case(s)
  12. 2021-02-13
    Survey response — day 14, dose 2
    MedDRA: Lymphadenopathy, Night sweats, Tachycardia — Feeling: Good · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit
    Free text: Lymphadenopathy and night sweats, tachycardia
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  13. 2021-02-13
    Report sent to call center — day 14, dose 2
    Get care from a doctor or other healthcare professional
    1 call case(s)
  14. 2021-02-20
    Survey response — day 21, dose 2
    MedDRA: Lymphadenopathy, Tachycardia — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: Continued supraclavicular lymphadenopathy and tachycardia.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  15. 2021-02-20
    Report sent to call center — day 21, dose 2
    Get care from a doctor or other healthcare professional
    1 call case(s)
  16. 2021-02-28
    Survey response — day 28, dose 2
    MedDRA: Lymphadenopathy, Night sweats, Tachycardia — Feeling: Good
    Free text: Persistent tachycardia, lymphadenopathy, and night sweats
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  17. 2021-03-07
    Survey response — day 35, dose 2
    MedDRA: Lymphadenopathy, Night sweats, Tachycardia, Unevaluable event — Feeling: Good · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    Free text: Symptoms: Night sweats, persisten lymphadenopathy, persistent tachycardia · Healthcare visit (other): Had labs drawn
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  18. 2021-03-07
    Report sent to call center — day 35, dose 2
    Get care from a doctor or other healthcare professional
    1 call case(s)
  19. 2021-03-15
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  20. 2021-05-01
    Survey response — 3 months, dose 2
    MedDRA: Lymphadenopathy, Night sweats — Feeling: Fair · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: Continued intermitent night sweats and lymphadenopathy requiring lymph node biopsy
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  21. 2021-05-01
    Report sent to call center — 3 months, dose 2
    Get care from a doctor or other healthcare professional
    1 call case(s)
  22. 2021-06-11
  23. 2021-07-31
    Health check-in — 6 months, dose 2
    Feeling: Good
    Adult check-in
  24. 2022-01-30
    Survey response — 12 months, dose 2
    MedDRA: Abortion spontaneous, Pregnancy — Feeling: Good · Be unable to work or attend school, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: Pregnant. Also had miscarriage 7/2021
    MedDRA releases: 2024-11 · check-in free text available
  25. 2022-01-30
    Report sent to call center — 12 months, dose 2
    Be unable to work or attend school · Get care from a doctor or other healthcare professional
    Outpatient clinic or urgent care clinic visit · 1 call case(s)
  26. 2022-01-31

Vaccinations

DoseDateManufacturerCo-administered
12020-12-28Moderna
22021-01-30Moderna

Call center

ReportedOutcomeVAERS-related outcome
2021-02-06 Unsuccessful
2021-02-13 Unsuccessful
2021-02-20 Unsuccessful
2021-03-07 Unsuccessful
2021-05-01 Unsuccessful
2022-01-30 Unsuccessful

Free text

Release 3 — days 1–6 daily, dose 2

2021-02-04

Systemic reaction (other): Lymphadenopathy

2021-02-05

Systemic reaction (other): Lymphadenopathy

Release 3 — day 7, dose 2

2021-02-06

Systemic reaction (other): Lymphadenopathy, night sweats

Release 4 — day 14, dose 2

2021-02-13

Symptoms: Lymphadenopathy and night sweats, tachycardia

Release 4 — day 21, dose 2

2021-02-20

Symptoms: Continued supraclavicular lymphadenopathy and tachycardia.

Release 4 — day 28, dose 2

2021-02-28

Symptoms: Persistent tachycardia, lymphadenopathy, and night sweats

Release 5 — day 35, dose 2

2021-03-07

Symptoms: Night sweats, persisten lymphadenopathy, persistent tachycardia
Healthcare visit (other): Had labs drawn

Release 8 — 3 months, dose 2

2021-05-01

Symptoms: Continued intermitent night sweats and lymphadenopathy requiring lymph node biopsy

Release 11 — 12 months, dose 2

2022-01-30

Symptoms: Pregnant. Also had miscarriage 7/2021

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
HCVOUnevaluable event ✓ ✓ ✓
SDAbortion spontaneous · · ✓
SDLymphadenopathy ✓ ✓ ✓
SDNight sweats ✓ ✓ ✓
SDPregnancy · · ✓
SDTachycardia ✓ ✓ ✓
SDUnevaluable event ○ ✓ ○
SROLymphadenopathy ✓ ✓ ✓
SRONight sweats ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release